The impact of the Covid-19 pandemic on breast cancer early detection and screening.

ABSTRACT: The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting delays to diagnosis and treatment may lead to more intensive treatment requirements and, potentially, increased mortality. Modelled evaluations can support responses to the pandemic by estimating short- and long-term outcomes for various scenarios. Multiple calibrated and validated models exist for

SUBMITTER: Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium 

PROVIDER: S-EPMC8241687 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature